Jeffrey Bluestone, Ph.D

University of California, San Francisco & Sonoma Biotherapeutics

Poster(s):

• Tu143 - Enhancing Regulatory T Cell Therapy with Orthogonal IL2-IL2R Systems to Restore Immune Tolerance in Type 1 Diabetes
  Tuesday, June 18, 2024

  6:00 PM – 7:30 PM PT